Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

February 01, 2005 (Vol. 25, No. 3)

Antibody Therapeutics Dominate Meeting

The Search for Cancer-Related Markers Continues

  • Recombinant antibody therapeutics are moving to a next generation of products, according to a keynote address by Ronald Levy, M.D., given at IBC's recent meeting held in San Diego, "Antibody Engineering and Therapeutics." Dr. Levy is a professor of medicine at Stanford, and was responsible for one of ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.